Gastroenterology and Hepatology

Episodes 1-15 of 15

• 

  MinuteCE®

  Improving Preventive Care of Patients With Hepatic Encephalopathy: Navigating the Subtleties and Beyond

  1.00 credit 9 episodes

  • 

    

    Robert S. Brown, Jr., MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 credit 9 episodes

• 

  RestartResume

  Hepatic Encephalopathy: An Ominous Sign

  RestartResume

  Hepatic Encephalopathy: An Ominous Sign

  MinuteCE®

  Hepatic Encephalopathy: An Ominous Sign

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  The Clinical Spectrum of Hepatic Encephalopathy 

  RestartResume

  The Clinical Spectrum of Hepatic Encephalopathy 

  MinuteCE®

  The Clinical Spectrum of Hepatic Encephalopathy 

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Hepatic Encephalopathy: Tipping the Balance 

  RestartResume

  Hepatic Encephalopathy: Tipping the Balance 

  MinuteCE®

  Hepatic Encephalopathy: Tipping the Balance 

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  You Can’t Diagnose MHE Unless You Diagnose Cirrhosis

  RestartResume

  You Can’t Diagnose MHE Unless You Diagnose Cirrhosis

  MinuteCE®

  You Can’t Diagnose MHE Unless You Diagnose Cirrhosis

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Diagnosing Minimal Hepatic Encephalopathy: There's an App for That?

  RestartResume

  Diagnosing Minimal Hepatic Encephalopathy: There's an App for That?

  MinuteCE®

  Diagnosing Minimal Hepatic Encephalopathy: There's an App for That?

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?

  RestartResume

  Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?

  MinuteCE®

  Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Treatment of Overt Hepatic Encephalopathy

  RestartResume

  Treatment of Overt Hepatic Encephalopathy

  MinuteCE®

  Treatment of Overt Hepatic Encephalopathy

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Hepatic Encephalopathy: Unmet Therapeutic Needs

  RestartResume

  Hepatic Encephalopathy: Unmet Therapeutic Needs

  MinuteCE®

  Hepatic Encephalopathy: Unmet Therapeutic Needs

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  RestartResume

  Advances in the Treatment of Hepatic Encephalopathy

  RestartResume

  Advances in the Treatment of Hepatic Encephalopathy

  MinuteCE®

  Advances in the Treatment of Hepatic Encephalopathy

  1.00 program credit

  • 

    

    Robert Brown Jr, MD, MPH

  • 

    

    Steven Flamm, MD

  1.00 program credit

• 

  MinuteCE®

  Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  

  0.50 credits 4 episodes

  • 

    

    James M. Cleary, MD, PhD

  0.50 credits 4 episodes

• 

  RestartResume

  Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers

  RestartResume

  Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers

  MinuteCE®

  Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers

  0.50 program credits

  • 

    

    James M. Cleary, MD, PhD

  0.50 program credits

• 

  RestartResume

  Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  

  RestartResume

  Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  

  MinuteCE®

  Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  

  0.50 program credits

  • 

    

    James M. Cleary, MD, PhD

  0.50 program credits

• 

  RestartResume

  Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers

  RestartResume

  Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers

  MinuteCE®

  Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers

  0.50 program credits

  • 

    

    James M. Cleary, MD, PhD

  0.50 program credits

• 

  RestartResume

  Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer

  RestartResume

  Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer

  MinuteCE®

  Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer

  0.50 program credits

  • 

    

    James M. Cleary, MD, PhD

  0.50 program credits